Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

medical   entities : Aethlon medical, inc.    save search

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices
Published: 2024-02-21 (Crawled : 13:00) - prnewswire.com
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 8.45% C: 3.03%

transfer medical agreement
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024
Published: 2024-02-07 (Crawled : 14:30) - biospace.com/
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: -2.81% H: 2.21% C: 2.21%

conference medical financial results
Exosome Research Market Worth $356 Million | MarketsandMarkets™
Published: 2024-01-17 (Crawled : 15:30) - prnewswire.com
DHR | $253.11 7.21% 0.9% 5.9M twitter stocktwits trandingview |
Health Technology
| | O: -0.53% H: 1.6% C: -0.43%
IESC | News | $127.65 8.47% 7.92% 170K twitter stocktwits trandingview |
Industrial Services
| | O: -1.06% H: 3.2% C: 2.44%
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: -3.09% H: 1.06% C: 0.53%

million research market
Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer
Published: 2023-11-13 (Crawled : 13:00) - prnewswire.com
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 9.88% C: -4.07%

medical
Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023
Published: 2023-11-06 (Crawled : 13:00) - prnewswire.com
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: -1.07% H: 4.32% C: 3.24%

conference medical financial results
Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology
Published: 2023-10-10 (Crawled : 12:00) - prnewswire.com
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: -2.23% H: 14.86% C: -1.71%

hemopurifier drug india clearance trial potential
Aethlon Announces Reverse Stock Split
Published: 2023-10-04 (Crawled : 12:00) - prnewswire.com
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: -5.91% H: 10.63% C: -5.27%


Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-08-30 (Crawled : 12:00) - prnewswire.com
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: 0.69% H: 0.0% C: -4.81%

conference global medical
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023
Published: 2023-08-03 (Crawled : 12:00) - prnewswire.com
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: 1.58% H: 4.97% C: -1.47%

conference medical financial results
Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant
Published: 2023-07-24 (Crawled : 12:00) - prnewswire.com
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: 8.47% H: 0.0% C: -6.65%

hemopurifier collaboration medical agreement
Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023
Published: 2023-06-22 (Crawled : 12:00) - prnewswire.com
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: -0.77% H: 0.91% C: 0.91%

conference year medical financial results
Aethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ Transplantation
Published: 2023-06-21 (Crawled : 12:00) - prnewswire.com
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: 2.3% H: 0.53% C: -0.03%

hemopurifier medical
Aethlon Medical to Participate in the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-Vest
Published: 2023-06-14 (Crawled : 12:00) - prnewswire.com
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: -0.15% H: 5.88% C: -0.59%

conference group medical
Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India
Published: 2023-05-22 (Crawled : 12:00) - prnewswire.com
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: -0.8% H: 8.03% C: 4.13%

covid-19 hemopurifier approval india ongoing medical trial
Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 13, 2023
Published: 2023-02-06 (Crawled : 15:00) - biospace.com/
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: 2.14% H: 3.01% C: -0.19%

conference medical financial results
Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023
Published: 2023-01-31 (Crawled : 13:20) - prnewswire.com
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: -9.18% H: 8.81% C: 1.79%

conference medical
Aethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in Cancer
Published: 2023-01-30 (Crawled : 13:20) - prnewswire.com
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: 27.66% H: 45.0% C: 4.57%

medical contract cancer hemopurifier
Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2022
Published: 2022-11-02 (Crawled : 19:00) - prnewswire.com
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: 5.55% H: 1.96% C: 0.0%

conference financial results
Aethlon Medical to Present at Two Investor Conferences in September
Published: 2022-09-06 (Crawled : 12:20) - prnewswire.com
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: 5.0% H: 0.0% C: -7.61%


Aethlon Medical Announces U.S. FDA Approval of Hemopurifier COVID-19 Study Protocol Amendment
Published: 2022-07-11 (Crawled : 13:20) - biospace.com/
AEMD A | $1.5119 2.16% 1.33% 17K twitter stocktwits trandingview |
Health Technology
| | O: -1.94% H: 4.95% C: 0.0%

covid-19 fda approval study
Gainers vs Losers
77% 23%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M twitter stocktwits trandingview |

AGBA | $2.97 137.6% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.59 75.27% 41.8% 2M twitter stocktwits trandingview |

ZAPP | $4.44 50.2% 33.12% 370K twitter stocktwits trandingview |
n/a

MTC | $2.24 43.59% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.15 40.0% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.045 35.33% 26.23% 870K twitter stocktwits trandingview |

HKIT | $1.33 30.39% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.35 29.81% 23.53% 7.1M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.5 25.0% 21.88% 280K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.